Filing Details
- Accession Number:
- 0001209191-19-002811
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-08 16:46:22
- Reporting Period:
- 2019-01-04
- Accepted Time:
- 2019-01-08 16:46:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1624033 | Yao Wenqing | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp, Head Of Discovery Chem | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-07 | 10,000 | $17.79 | 45,217 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-07 | 10,000 | $75.00 | 35,217 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-07 | 808 | $74.21 | 34,409 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2019-01-04 | 22,772 | $0.00 | 22,772 | $72.27 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-01-07 | 10,000 | $0.00 | 10,000 | $17.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,772 | 2029-01-03 | No | 4 | A | Direct | |
| 15,354 | 2019-01-18 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
- This includes an aggregate of 5,416 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.
- Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
Billionaire Hedge Funds
